Bin Lian

3.6k total citations
154 papers, 1.8k citations indexed

About

Bin Lian is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Bin Lian has authored 154 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Oncology, 66 papers in Molecular Biology and 31 papers in Immunology. Recurrent topics in Bin Lian's work include Cutaneous Melanoma Detection and Management (46 papers), Cancer Immunotherapy and Biomarkers (42 papers) and CAR-T cell therapy research (40 papers). Bin Lian is often cited by papers focused on Cutaneous Melanoma Detection and Management (46 papers), Cancer Immunotherapy and Biomarkers (42 papers) and CAR-T cell therapy research (40 papers). Bin Lian collaborates with scholars based in China, Ethiopia and United States. Bin Lian's co-authors include Lu Si, Xinan Sheng, Chuanliang Cui, Jun Guo, Zhihong Chi, Bixia Tang, Yan Kong, Lili Mao, Xieqiao Yan and Li Zhou and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Bin Lian

137 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Lian China 23 1.2k 728 403 242 231 154 1.8k
Anastasia Constantinidou Cyprus 26 994 0.8× 457 0.6× 250 0.6× 846 3.5× 253 1.1× 90 2.3k
Jabed Iqbal Singapore 27 1.2k 1.0× 573 0.8× 624 1.5× 264 1.1× 206 0.9× 69 2.2k
Bruce G. Ward Australia 26 720 0.6× 700 1.0× 319 0.8× 214 0.9× 274 1.2× 57 2.3k
Katy K. Tsai United States 20 1.9k 1.6× 570 0.8× 943 2.3× 325 1.3× 114 0.5× 73 2.4k
Emma V. King United Kingdom 18 954 0.8× 467 0.6× 694 1.7× 273 1.1× 256 1.1× 52 2.0k
Marc F. Hansen United States 22 1.2k 1.0× 1.2k 1.6× 111 0.3× 538 2.2× 123 0.5× 57 2.6k
J.C. Soria France 21 1.4k 1.2× 1.0k 1.4× 529 1.3× 980 4.0× 226 1.0× 124 2.8k
Heidi V. Russell United States 23 2.3k 2.0× 962 1.3× 1.1k 2.7× 202 0.8× 138 0.6× 74 3.5k
David Arguello United States 14 542 0.5× 227 0.3× 147 0.4× 199 0.8× 194 0.8× 47 931
Geraint T. Williams United Kingdom 18 926 0.8× 688 0.9× 251 0.6× 305 1.3× 472 2.0× 36 2.4k

Countries citing papers authored by Bin Lian

Since Specialization
Citations

This map shows the geographic impact of Bin Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Lian more than expected).

Fields of papers citing papers by Bin Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Lian. The network helps show where Bin Lian may publish in the future.

Co-authorship network of co-authors of Bin Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Lian. A scholar is included among the top collaborators of Bin Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Lian. Bin Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yunping, et al.. (2024). CIU-L: A class-incremental learning and machine unlearning passive sensing system for human identification. Pervasive and Mobile Computing. 103. 101947–101947. 1 indexed citations
2.
Chen, Wei, et al.. (2024). CATFSID: A few-shot human identification system based on cross-domain adversarial training. Computer Communications. 224. 275–284. 1 indexed citations
3.
4.
Mao, Lili, Jie Dai, Xue Bai, et al.. (2024). Tucidinostat plus toripalimab in patients with unresectable or metastatic melanoma: An open-label, single-arm phase II study.. Journal of Clinical Oncology. 42(16_suppl). e21527–e21527. 1 indexed citations
5.
Tang, Bixia, Rong Duan, Xieqiao Yan, et al.. (2024). Natural history of bone-only metastasis in renal cell carcinoma. Urologic Oncology Seminars and Original Investigations. 42(4). 119.e17–119.e22. 1 indexed citations
6.
7.
Dai, Jie, Xiaoting Wei, Xue Bai, et al.. (2024). Pembrolizumab Versus High-Dose Interferon-α2b as Adjuvant Therapy for Pediatric Melanoma: A Retrospective Study. Dermatology Practical & Conceptual. 14(1). e2024026–e2024026. 1 indexed citations
8.
9.
Cui, Chuanliang, Xuan Wang, Bin Lian, et al.. (2022). OrienX010, an oncolytic virus, in patients with unresectable stage IIIC–IV melanoma: a phase Ib study. Journal for ImmunoTherapy of Cancer. 10(4). e004307–e004307. 38 indexed citations
10.
Li, Siming, Xiaowen Wu, Xieqiao Yan, et al.. (2022). Toripalimab plus axitinib in patients with metastatic mucosal melanoma: 3-year survival update and biomarker analysis. Journal for ImmunoTherapy of Cancer. 10(2). e004036–e004036. 33 indexed citations
11.
12.
Yan, Xieqiao, Xinan Sheng, Zhihong Chi, et al.. (2021). Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma. Journal of Clinical Oncology. 39(8). 881–889. 36 indexed citations
13.
Xu, Weiran, et al.. (2021). The combination therapy with the cytotoxic T lymphocyte-associated antigen-4 and programmed death 1 antibody-induced asthma in a patient with advanced melanoma. Journal of Cancer Research and Therapeutics. 17(3). 808–810. 7 indexed citations
14.
Jiang, Wenbo, Chanchan Xiao, Wentao Yang, et al.. (2020). Sodium Butyrate Combined with Docetaxel for the Treatment of Lung Adenocarcinoma A549 Cells by Targeting Gli1. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Zheng, Nan, et al.. (2018). Development of a Subcellular Semimechanism-Based Pharmacokinetic/Pharmacodynamic Model to Characterize Paclitaxel Effects Delivered by Polymeric Micelles. Journal of Pharmaceutical Sciences. 108(1). 725–731. 6 indexed citations
16.
Sheng, Xinan, Dengfeng Cao, Jianlin Yuan, et al.. (2018). Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 study. European Journal of Cancer. 100. 1–7. 37 indexed citations
17.
Bai, Xue, Yan Kong, Zhihong Chi, et al.. (2017). MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases. Clinical Cancer Research. 23(20). 6120–6127. 72 indexed citations
18.
Tan, Qixing, Qinghong Qin, Weiping Yang, Bin Lian, & Changyuan Wei. (2014). Prognostic value of hormone receptor status conversion following neoadjuvant chemotherapy in a series of operable breast cancer patients.. PubMed. 7(7). 4086–94. 14 indexed citations
19.
Dai, Jie, Yan Kong, Lu Si, et al.. (2013). Large-scale Analysis of PDGFRA Mutations in Melanomas and Evaluation of Their Sensitivity to Tyrosine Kinase Inhibitors Imatinib and Crenolanib. Clinical Cancer Research. 19(24). 6935–6942. 38 indexed citations
20.
Lian, Bin, Lu Si, Chuanliang Cui, et al.. (2013). Phase II Randomized Trial Comparing High-Dose IFN-α2b with Temozolomide Plus Cisplatin as Systemic Adjuvant Therapy for Resected Mucosal Melanoma. Clinical Cancer Research. 19(16). 4488–4498. 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasia Constantinidou Breakdown of academic impact, for papers by Jabed Iqbal Breakdown of academic impact, for papers by Bruce G. Ward Breakdown of academic impact, for papers by Katy K. Tsai Breakdown of academic impact, for papers by Emma V. King Breakdown of academic impact, for papers by Marc F. Hansen Breakdown of academic impact, for papers by J.C. Soria Breakdown of academic impact, for papers by Heidi V. Russell Breakdown of academic impact, for papers by David Arguello Breakdown of academic impact, for papers by Geraint T. Williams
Rankless by CCL
2026